Boston Scientific Corporation vs Redwire Corporation — how do they compare? Boston Scientific Corporation trades at $50.96 (market cap $74.19B), while Redwire Corporation trades at $13.6 (market cap $3.38B). The key difference: Boston Scientific Corporation is far larger — about 21.9× Redwire Corporation's market cap, and Redwire Corporation is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | RDW | |
|---|---|---|
Market Cap | $74.19B | $3.38B |
Sector | Health | Technology |
52-Week High | $108.14 | $25.90 |
52-Week Low | $42.63 | $5.06 |
Enterprise Value | $86.27B | $2.91B |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →